[HTML][HTML] Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial

JE Norman, N Marlow, CM Messow, A Shennan… - The lancet, 2016 - thelancet.com
Background Progesterone administration has been shown to reduce the risk of preterm birth
and neonatal morbidity in women at high risk, but there is uncertainty about longer term …

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial

JE Norman, N Marlow, CM Messow, A Shennan… - Lancet, 2016 - eprints.ncl.ac.uk
Background Progesterone administration has been shown to reduce the risk of preterm birth
and neonatal morbidity in women at high risk, but there is uncertainty about longer term …

[PDF][PDF] Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial

JE Norman, N Marlow, CM Messow, A Shennan… - 2016 - sdb.unipd.it
Background Progesterone administration has been shown to reduce the risk of preterm birth
and neonatal morbidity in women at high risk, but there is uncertainty about longer term …

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.

JE Norman, N Marlow, CM Messow… - Lancet (London …, 2016 - europepmc.org
Background Progesterone administration has been shown to reduce the risk of preterm birth
and neonatal morbidity in women at high risk, but there is uncertainty about longer term …

[PDF][PDF] Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial

JE Norman, N Marlow, CM Messow, A Shennan… - LANCET, 2016 - qmro.qmul.ac.uk
Background Progesterone administration has been shown to reduce the risk of preterm birth
and neonatal morbidity in women at high risk, but there is uncertainty about longer term …

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial

JE Norman, N Marlow, CM Messow, A Shennan… - 2016 - pubmed.ncbi.nlm.nih.gov
Background Progesterone administration has been shown to reduce the risk of preterm birth
and neonatal morbidity in women at high risk, but there is uncertainty about longer term …

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial

OPPTIMUM study group - The Lancet, 2016 - research.ed.ac.uk
Background: Progesterone administration has been shown to reduce the risk of preterm birth
and neonatal morbidity in women at high risk, but there is uncertainty about longer term …

[PDF][PDF] Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial

JE Norman, N Marlow, CM Messow, A Shennan… - Lancet, 2016 - core.ac.uk
Background Progesterone administration has been shown to reduce the risk of preterm birth
and neonatal morbidity in women at high risk, but there is uncertainty about longer term …

[PDF][PDF] Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial

JE Norman, N Marlow, CM Messow, A Shennan… - 2016 - sdb.unipd.it
Background Progesterone administration has been shown to reduce the risk of preterm birth
and neonatal morbidity in women at high risk, but there is uncertainty about longer term …

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial

JE Norman, N Marlow, CM Messow, A Shennan… - Lancet, 2016 - eprints.gla.ac.uk
Background Progesterone administration has been shown to reduce the risk of preterm birth
and neonatal morbidity in women at high risk, but there is uncertainty about longer term …